BioSpace News Archive

Encompass Health Corp., a national leader in post-acute care, announced it has entered into a definitive agreement to purchase the home health and hospice assets of Frontier Home Health and Hospice in Alaska, Colorado, Montana, Washington and Wyoming.

TAAG Genetics is proud to announce our expansion into the United States with the opening of a new laboratory in St. Charles, IL.

The American Pharmacists Association and the American Society of Health-System Pharmacists hailed the introduction of bipartisan legislation in the U.S. Senate that would give tens of millions of Medicare patients in medically underserved communities access to critically needed primary health care services delivered by pharmacists.

Lantern Pharma (NASDAQ: LTRN) , a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform to improve drug discovery and development, and identify patients who will benefit from its portfolio of targeted oncology therapeutics, announced today that it will host a conference call

Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS). Dear Shareholders, In the context of the Covid-19 pandemic and in accordance with Ordinance no. 2020-321 of March 25, 2020, the provisions of which were extended until July 31, 2021 by Decree no. 2021-255 of March 9, 2021, this general meeting will be held in closed session, i.e. without the physical presence of the shareholders and persons who are usually able to attend.

Q-State Biosciences (“Q-State”), a discovery-stage therapeutics and technology company advancing programs for the treatment of epilepsy, pain, and other disorders of the central nervous system, announced today three new appointments to its executive leadership team: Dr. Graham Dempsey, Ph.D., has been appointed to the position of Chief Scientific Officer and Head of Research and Development;

Approximately 30,000-60,000 Patients in the United States Are Affected With Alport Syndrome, a Life-Threatening Disease With No Approved Therapies Application Assigned a P DUFA Date of February 25, 2022

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the United States Patent Office (USPTO) issued U.S. Patent No. 10,981,981 with an expiry of May 2034.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its voluntary licensing partners with technical assistance, support for the addition of new local manufacturing facilities and the donation of active pharmaceutical ingredient (API) to rapidly scale up production of remdesivir

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2021 financial results on Friday, May 7, 2021.